Neurobehavioral Effects of β-Escin

Author(s): Huda J. Waheed , Saad B. Nashtar , Ali I. Al-Gareeb , Hayder M. Al-Kuraishy* .

Journal Name: Current Psychopharmacology

Volume 8 , Issue 1 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Aescin or β-escin is the main and active constituent of horse chestnut seed (Aesculus hippocastanum) used for the treatment of inflammatory edema, venous insufficiency and ischemic ulcerations. Aescin has many actions due to induction of endothelial nitric oxide and prostaglandin F2-α production moreover; aescin antagonizes the effect of histamine and 5HT at receptor levels.

Objective: The aim of the present study was to evaluate the neurobehavioral effects of aescin on normal healthy volunteers.

Method: A total number of 65 healthy participants with mean age of 21+1.1 years were recruited to study the effects of aescin on the neurobehavioral effects of normal healthy volunteers compared to placebo. The neurobehavioral effects were assessed by psychomotor performances and sensorimotor reaction, cortical arousal and central integrity processes and assessment of memory capacity.

Results: Placebo produced insignificant amelioration of TRT and RRT p>0.05, with mild significant effect on MRT p=0.03. Aescin produced a significant effect in the amelioration of psychomotor performances and sensorimotor reaction p=0.0001. Regarding the differential effect of placebo and aescin on the cortical arousal and central integrity processes, placebo illustrated insignificant effect at p>0.05 whereas; aescin showed mild significant effect on Critical Fusion Frequency (CFFA) p<0.05 and highly significant effect on the other parameters p<0.01 except for critical-fusion frequency threshold when aescin illustrated insignificant effect at p>0.05. Aescin illustrated significant acceleration of ІІ-back WMA, ІІІ-back WMA and Second trial Short-Term Memory (STM) at p<0.01 compared to the placebo effect.

Conclusion: Short-term therapy with aescin improves the neurobehavioral effects on healthy volunteers.

Keywords: Neurobehavioral, Aescin , placebo, β-escin, psychomotor, sensorimotor, cortical arousal.

[1]
Singh H, Sidhu S, Chopra K, Khan MU. The novel role of β-aescin in attenuating CCl4-induced hepatotoxicity in rats. Pharm Biol 2017; 55(1): 749-57.
[2]
Zhang L, Wang H, Wang T, et al. Potent anti-inflammatory agent escin does not affect the healing of tibia fracture and abdominal wound in an animal model. Exp Ther Med 2012; 3(4): 735-9.
[3]
Wang Y, Xu X, Zhao P, Tong B, Wei Z, Dai Y. Escin Ia suppresses the metastasis of triple-negative breast cancer by inhibiting epithelial-mesenchymal transition via downregulating LOXL2 expression. Oncotarget. 2016; 26; 7(17): 23684-99.
[4]
Domanski D, Zegrocka-Stendel O, Perzanowska A, et al. Molecular mechanism for cellular response to β-Escin and its therapeutic implications. PLoS One 2016; 11(10): e0164365.
[5]
Gupta SC, Tyagi AK, Deshmukh-Taskar P, Hinojosa M, Prasad S, Aggarwal BB. Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols. Arch Biochem Biophys 2014; 559: 91-9.
[6]
Martínez-Miguel P, Medrano-Andrés D, Griera-Merino M, et al. Tweak up-regulates endothelin-1 system in mouse and human endothelial cells. Cardiovasc Res 2017; 113(2): 207-21.
[7]
Harikumar KB, Sung B, Pandey MK, Guha S, Krishnan S, Aggarwal BB. Escin, a pentacyclic triterpene, chemosensitizes human tumor cells through inhibition of nuclearfactor-kappaB signaling pathway. Mol Pharmacol 2010; 77(5): 818-27.
[8]
Hiai S, Yokoyama H, Oura H. Effect of escin on adrenocorticotropin and corticosterone levels in rat plasma. Chem Pharm Bull (Tokyo) 1981; 29(2): 490-4.
[9]
Selvakumar GP, Janakiraman U, Essa MM, Justin TA, Manivasagam T. Escin attenuates behavioral impairments, oxidative stress and inflammation in a chronic MPTP/probenecid mouse model of Parkinson’s disease. Brain Res 2014; 1585: 23-36.
[10]
Al-kuraishy HM, Al-Gareeb AI. Eustress and Malondialdehyde (MDA): Role of Panax Ginseng: Randomized, Placebo Controlled Study. Iran J Psychiatry 2017; 12(3): 194-200.
[11]
Al-Kuraishy HM. 1 Al-Gareeb AI. Co-administration effects of α-lipoic acid and nucleo CMP on arousal and sensory cortical activity. J Young Pharm 2016; 8(1): 12-7.
[12]
Al-Kuraishy HM. Central additive effect of Ginkgo biloba and Rhodiola rosea on psychomotor vigilance task and short-term working memory accuracy. J Intercult Ethnopharmacol 2015; 5(1): 7-13.
[13]
Zhang L, Fu F, Zhang X, Zhu M, Wang T, Fan H. Escin attenuates cognitive deficits and hippocampal injury after transient global cerebralischemia in mice via regulating certain inflammatory genes. Neurochem Int 2010; 57(2): 119-27.
[14]
Draganich C, Erdal K. Placebo sleep affects cognitive functioning. J Exp Psychol Learn Mem Cogn 2014; 40(3): 857-64.
[15]
Stern J, Candia V, Porchet RI, et al. Placebo-mediated, Naloxone-sensitive suggestibility of short-term memory performance. Neurobiol Learn Mem 2011; 95(3): 326-34.
[16]
De la Fuente-Fernández R. The placebo-reward hypothesis: Dopamine and the placebo effect. Parkinsonism Relat Disord 2009; 15(Suppl. 3): S72-4.
[17]
Rafiq SI, Jan K, Singh S, Saxena DC. Physicochemical, pasting, rheological, thermal and morphological properties of horse chestnutstarch. J Food Sci Technol 2015; 52(9): 5651-60.
[18]
Margină D, Olaru OT, Ilie M, et al. Assessment of the potential health benefits of certain total extracts from Vitis vinifera, Aesculus hyppocastanum and Curcuma longa. Exp Ther Med 2015; 10(5): 1681-8.
[19]
Qiu Z, Yue S. Curcumin improves learning and memory function through decreasing hippocampal TNF-α and iNOS levels after subarachnoid hemorrhage in rats. Xibao Yu Fenzi Mianyixue Zazhi 2016; 32(3): 343-6.
[20]
Guo C, Shen J, Meng Z, Yang X, Li F. Neuroprotective effects of polygalacic acid on scopolamine-induced memory deficits in mice. Phytomedicine 2016; 23(2): 149-55.
[21]
Wankhar W, Srinivasan S, Sundareswaran L, Wankhar D, Rajan R, Sheeladevi R. Role of Scoparia dulcis linn on noise-induced Nitric Oxide Synthase (NOS) expression and neurotransmitter assessment on motor function in Wistar albino rats. Biomed Pharmacother 2017; 86: 475-81.
[22]
Yoshikawa K, Takei S, Hasegawa-Ishii S, et al. Preferential localization of prostamide/prostaglandin F synthase in myelin sheaths of the central nervous system. Brain Res 2011; 1367: 22-32.
[23]
Hartline Daniel K. What is myelin? Neuron Glia Biol 2008; 4: 153-63.
[24]
Santhi N, Lazar AS, McCabe PJ, Lo JC, Groeger JA, Dijk DJ. Sex differences in the circadian regulation of sleep and waking cognition in humans. Proc Natl Acad Sci USA 2016; 113(19): E2730-9.
[25]
Beijamini F, Silva AG, Peixoto CA, Louzada FM. Influence of gender on psychomotor vigilance task performance by adolescents. Braz J Med Biol Res 2008; 41(8): 734-8.
[26]
Kagerer FA. Nondominant-to-dominant hand interference in bimanual movements is facilitated by gradual visuomotor perturbation. Neuroscience 2016; 318: 94-103.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 8
ISSUE: 1
Year: 2019
Page: [79 - 86]
Pages: 8
DOI: 10.2174/2211556007666180523103828
Price: $58

Article Metrics

PDF: 47
HTML: 1